effect overlay
activetrials
Stroke

Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
 

HREC: 2023.132
Principal Investigator: Prof Bruce Campbell
Coordinator contact: David Jackson
Funding: Non-Commercial
Stroke

A Phase II, Multicenter, Double Blinded, Randomized, Placebo Controlled, Parallel-Group, Single-Dose Study to Determine the Safety, Preliminary Efficacy,and Pharmacokinetics of ARG 007 in Acute Ischemic Stroke Patients
 

HREC: 2023.189
Principal Investigator: Prof Bruce Campbell
Coordinator contact:
Funding: Commercial
Traumatic Brain Injury (TBI)

A prospective study of language function following surgical resection of left hemisphere primary brain tumours

HREC: 2015.012
Principal Investigator: A/Prof Sandy Shultz
Coordinator contact:
Funding: Non-Commercial
Peripheral Neuropathy

Efficacy of Botulinum Toxin Type A in the Targeted Treatment of Nocturnal Bruxism: A Double-Blind, Randomized, Placebo-Controlled, Cross-over Study 
 

HREC: 2015.195
Principal Investigator: A/Prof Lynette Kiers
Coordinator contact: Dr Thanuja Dharmadasa
Funding: Non-Commercial
Neuro-Ophthalmology

Prospective Neuro-Ophthalmology database (NODE) towards developing comprehensive longitudinal outcome measures for neuro-ophthalmic diseases
 

HREC: 2020.336
Principal Investigator: Dr Anthony Fok
Coordinator contact:
Funding: Non-Commercial